Center for American Progress Highlights Pitfalls of Tort Reform

A few weeks ago, the Center for American Progress published a short video detailing the deleterious effects tort reform has on public safety in Texas.  Here’s what they had to say about their video: “A new video from Legal Progress, the legal policy program at the Center for American Progress, documents the damaging effects of

Congress seeks explanation for generic drug price spike

Last month, members of the US Congress sent letters to 14 generic drug manufacturers, demanding explanation for the recent, dramatic spike in the price of some 20 generic drugs.  The Generic Pharmaceutical Association, a trade group representing the generic pharmaceutical industry, blames the increase on simple market forces, but many are suspicious of that response.

More Bogus Arguments by Proponents of Tort Reform

After several states passed tort reform legislation in 2004, the Economic Policy Institute published a report titled “The frivolous case for tort law change: Opponents of the legal system exaggerate its costs, ignore its benefits,” that revealed a number of important flaws in the argument for the necessity for and benefit from tort reform. Many

Are Surrogate Markers Too Low a Bar for FDA Approval?

The recent approval of a drug for use in combating leukemia by the US Food and Drug Administration has shed light on the relatively controversial, albeit common practice by that organization of using surrogate markers of efficacy for determining the benefit of a given drug or therapy.  Some believe this constitutes a low bar for

Three Myths About Tort Reform

Tort reform has sullied the political landscape of this country for years.  A set of proposed laws and regulations at both the state and federal level, one central aim of tort reform is to limit the compensation an injured party can recover in a personal injury lawsuit, or “tort,” attempting to “save” health care from

Case Report: Cymbalta Withdrawal Persists for 10 Months

In January, 2014, an article published in The Journal of Neuropsychiatry and Clinical Neurosciences titled “Long-Term Duloxetine Withdrawal Syndrome and Management in a Depressed Patient” reported on a depressed patient who used Cymbalta (duloxetine), discontinued the drug, and faced long-term withdrawal symptoms. After using Cymbalta (60mg/day) for one year, the patient, called “Miss B” in

Xarelto Lawsuit Information

WARNING: Xarelto Linked to Fatal Internal Bleeding, No Reversal Agent Recently, the anticoagulant drug Xarelto (rivaroxaban) has come under increased scrutiny by both the United States Food and Drug Administration and medical professionals alike, citing an increased risk for internal bleeding.  Unfortunately, there is as yet no reversal agent for the drug. Due to inadequate

Surgical Removals of Mirena IUD Increasing

A number of lawsuits have arisen due to the complications caused by the use of intrauterine contraceptive devices (IUDs).  It has been shown that with the increase in popularity of IUDs, there has been a notable rise of cases where migration of the devices leads to a need for corrective surgery for the removal of